🔓 Unlock the full profile of Tassos Gianakakos (Kardigan), including verified contact details, financial insights, and professional associations.
See Tassos Gianakakos Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: tas*****@kar******.com
Mobile: 66149*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Tassos Gianakakos is currently serving as the Co-founder, Chief Executive Officer, and Chair of Kardigan, a biotechnology company founded in August 2023, based in Menlo Park, California.
- Under the leadership of Gianakakos, Kardigan aims to advance innovations in biotechnology, focusing on solutions that improve patient care and health outcomes.
- Prior to establishing Kardigan, Gianakakos co-founded Prolaio in November 2021, also serving as CEO and Chair, contributing to its growth in the biotech sector.
- Gianakakos has a significant tenure as Chief Executive Officer at MyoKardia from October 2013 to November 2020, where strategic decisions led to advancements in cardiovascular treatments.
- From 2011 to 2013, Gianakakos held various senior roles at MAP Pharmaceuticals, including SVP, Chief Business Officer, and SVP Corporate & Business Development, driving development initiatives in innovative therapeutics.
- During time at Codexis from 2002 to 2006, Gianakakos served as SVP of Business Development, where efforts contributed to expanding the company's pharmaceutical capabilities.
- Gianakakos began their career as a Process Engineer at Merck, where foundational skills in process optimization were developed and applied in later roles.
- Throughout the career path, Gianakakos has demonstrated a strong ability to lead teams and organizations towards achieving significant milestones in the biotechnology and pharmaceutical industries.